# A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels

> **NCT01419236** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 76 (actual)

## Conditions studied

- Ejaculatory Dysfunction
- Hypogonadism

## Interventions

- **DRUG:** Testosterone Solution 2%
- **DRUG:** Placebo Solution

## Key facts

- **NCT ID:** NCT01419236
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2014-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01419236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01419236, "A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01419236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*